NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Polly A. MurphyDirector2026-05-186,100$4.17
$25.44kBuy
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-03-1160,000$1.24
$74.40kBuy
Jeanpierre SommadossiPresident CEO and Chairman2026-02-03300,000$1.24
$372.00kBuy
Maria Arantxa HorgaChief Medical Officer2026-01-3116,073$4.24
$68.15kSell
Jeanpierre SommadossiPresident CEO and Chairman2026-01-31106,093$4.24
$449.83kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-01-3116,104$4.24
$68.28kSell
John VavrickaChief Commercial Officer2026-01-3111,570$4.24
$49.06kSell
Wayne FosterEVP Chief Accounting Officer2026-01-3112,132$4.24
$51.44kSell
Janet Mj HammondChief Development Officer2026-01-3114,136$4.24
$59.94kSell

1 of 1

AVIR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.93%11,950,772$59.51MInstitution
Blackrock Inc10.54%8,435,437$42.01MInstitution
Bml Capital Management LLC8.82%7,058,657$35.15MInstitution
Jeanpierre Sommadossi8.29%6,633,855$33.04MInsider
Cormorant Asset Management LP8.01%6,411,355$31.93MInsider
Andrew A. F. Hack7.02%5,615,659$27.97MInsider
Tang Capital Management LLC6.02%4,814,700$23.98MInstitution
Vanguard Capital Management LLC4.06%3,246,124$16.17MInstitution
Bain Capital Life Sciences Investors LLC2.95%2,360,638$11.76MInstitution
Two Sigma Investments LP2.33%1,864,164$9.28MInstitution

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR72.68%27.32%Net BuyingNet Buying
VSTM61.90%38.10%Net SellingNet Selling
PRLD38.64%51.23%Net BuyingNet Buying
XFOR92.18%7.82%Net BuyingNet Selling
UPB71.16%28.84%Net SellingNet Selling

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 75.10% institutional shareholders, 28.22% Atea Pharmaceuticals insiders, and 0.00% retail investors. Jeanpierre Sommadossi is the largest individual Atea Pharmaceuticals shareholder, owning 6.63M shares representing 8.29% of the company. Jeanpierre Sommadossi's Atea Pharmaceuticals shares are currently valued at $33.04M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.